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Abstract. – OBJECTIVE: Dissociative symp-
toms are frequent among psychiatric patients
and may considerably affect patients’ psy-
chopathological condition and treatment out-
comes. The objectives of the study are to assess
the presence of dissociative symptoms in fe-
male patients with mood and anxiety disorders,
to investigate their correlation with the clinical
severity of the disorders and to investigate those
personality traits that are more frequent in pa-
tients with high levels of dissociation.
PATIENTS AND METHODS: 50 Caucasian fe-
males were enrolled in the study. Patients were as-
sessed through the Self-Report Symptom Check-
List, the Dissociative Experiences Scale (DES) and
rating scales for Depression and Anxiety.
RESULTS: The mean DES score in the overall
sample was 16.6. 32% of patients had a DES
score > 20. Depressive symptoms positively cor-
related with the DES total scores. Dissociator pa-
tients presented some significantly different tem-
peramental characteristics in comparison with
non dissociator patients.
CONCLUSIONS: Dissociative symptoms are
highly present in patients with mood and anxiety
disorders and correlate with the severity of de-
pressive symptoms. Specific personality traits
more frequently observed in dissociator people
may represent predisposing factors; their early
identification could be clinically relevant.
Key Words:
Anxiety disorders, Dissociation, Dissociative symptoms,
Mood disorders, Personality traits, Temperament.
Introduction
According to Bernstein and Putnam1, “dissocia-
tion is the lack of normal integration of thoughts,
feelings, and experiences into the stream of con-
sciousness and memory”. In Both DSM-IV and
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DSM-5 dissociative disorders include a range of
symptoms and manifestations like derealization,
depersonalization, psychogenic amnesia and con-
fusion about one’s own identity2,3. For several
years, dissociative symptoms (DS) have been con-
sidered as border conditions between normality
and psychopathology4.
It has been shown that DS are phenomena
commonly found in the general population5,6.
Moreover, DS like depersonalization or dereal-
ization are frequent in several psychiatric disor-
ders including panic disorder, obsessive compul-
sive disorder, post-traumatic stress, insomnia,
borderline personality, delirium, conversion dis-
order, depression and bipolar disorder7-19.
DS are often not clinically recognized; this
fact may be related to the absence of appropriate
diagnostic instruments. Clinicians are often not
trained to observe dissociative phenomena and
patients have difficulty in spontaneously report-
ing this kind of experiences5.
DS are frequent, with a female male ratio of
9:1, and they may considerably affect patients’
psychopathological condition and treatment out-
comes6,20. The aims of the present study are (1) to
assess the presence of DS in female patients with
mood and anxiety disorders, (2) to investigate a
possible correlation between the clinical severity
of the disorders and DS and (3) to investigate
those personality traits more frequent in people
with high levels of DS.
Patients and Methods
Sample
Female patients consecutively admitted to the
Psychiatric Outpatient Unit of A. Fiorini Universi-
2014; 18: 3217-3222
SCL-90
GSI SOM OBS SENS DEPR ANX HOST PHOB PARAN PSYC
Min 0 0 0 0 0 0 0 0 0 0
Max 3.22 3.36 4 3.11 3.75 3.07 3.5 2.71 3.6 3
Mean 1.30 1.33 1.55 0.84 1.46 1.40 0.83 0.57 1.20 0.60
St. Dev 0.73 0.81 1.03 0.89 0.93 0.77 0.84 0.74 0.96 0.71
TCI
NS HA RD P SD C ST
Min 17.5 37.143 18.75 25 18.182 35.714 18.182
Max 82.8597 97.143 84.667 100 88.636 92.857 83.704
Mean 52.29 65.51 55.93 59.25 56.34 71.48 47.89
St. Dev 14.39 13.24 13.87 21.79 14.47 13.35 16.96
DES
Total score AMN ABS DEP-DER
Min 0 0 0 0
Max 49.75 80 80 77.5
Mean 16.60 13.12 23.25 13.83
St. Dev 14.64 17.07 18.01 16.97
Table I. SCL-90, TCI and DES scores in the overall sample.
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ty Hospital of Terracina, Sapienza University of
Rome, were considered for participation in the
study. Inclusion criteria were: age 18-75; DSM-IV
TR diagnosis of a mood or anxiety disorder; Hamil-
ton Depression Rating Scale (HAM-D) and Hamil-
ton Anxiety Scale (HAM-A) total score ≥ 18. Ex-
clusion criteria were: illiteracy; psycho-organic
deficits; co-morbidity with psychotic disorders.
50 Caucasian females were enrolled in the
study; mean age was 46.22 ± 5.51. 26 patients met
criteria for a Mood Disorder (18 Major Depressive
Disorder and 8 Bipolar Disorder) and 24 met crite-
ria for an Anxiety Disorder (15 Generalized Anxi-
ety Disorder; 9 Panic Disorder).
The diagnosis was made through the Struc-
tured Clinical Interview for DSM-IV-TR. Pa-
tients were clinically assessed through the fol-
lowing scales: Dissociative Experiences Scale
(DES)1; Temperament and Character Inventory
(TCI)21; HAM-D22 and HAM-A23; Self-Report
Symptom Check-List (SCL-90)24.
The mean time of administration of scales was
67 min; at the time of clinical assessment 35 pa-
tients were drug-free and 21 were under pharma-
cological treatments.
Clinical Measures
TCI21 is an inventory for personality traits. It
operates with seven dimensions of personality
traits: four temperaments (Harm Avoidance -
HA; Reward Dependence - RD; Novelty Seeking
- NS; Persistence - P) and three characters (Self-
directiveness - SD; Cooperativeness - C; Self-
transcendence - ST).
SCL-9024 is a relatively brief self-report vali-
dated questionnaire designed to evaluate a broad
range of psychological problems and symptoms
of psychopathology. The scale investigates differ-
ent symptomatological areas such as somatiza-
tion (SOM), obsession and rituals (OBS), diffi-
culty in relationships (SENS), depressive (DEP)
or anxious (ANX) symptoms, violent behaviors
or anger (HOST), panic disorder (PHOB), diffi-
dence or paranoia (PARAN) and presence of psy-
chosis (delusions, hallucinations, etc) (PSYC).
The Global Severity Index (GSI), that describes
the psychopathological distress, was also consid-
ered.
DES1 is a self-rating scale measuring the ten-
dency to experience dissociative states in daily
life (total range: 0-100). It includes 3 subscales:
Amnesia (AMN), Absorption (ABS) and Deper-
sonalization-Derealization (DEP-DER).
HAM-D22 and HAM-A23 are validated multi-
ple item questionnaires used to provide an indi-
cation of depression and anxiety.
Statistical Analysis
Based on the DES total score, patients with
higher presence of dissociative experiences (DES
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DES
total score
HAM-A Pearson’s Correlation 0.216
Sig. (2-tailed) 0.145
HAM-D Pearson’s Correlation 0.354*
Sig. (2-tailed) 0.017
TCI
NS Pearson’s Correlation -0.158
Sig. (2-tailed) 0.279
HA Pearson’s Correlation 0.058
Sig. (2-tailed) 0.690
RD Pearson’s Correlation 0.255
Sig. (2-tailed) 0.078
P Pearson’s Correlation 0.006
Sig. (2-tailed) 0.967
SD Pearson’s Correlation 0.327*
Sig. (2-tailed) 0.022
C Pearson’s Correlation 0.112
Sig. (2-tailed) 0.468
ST Pearson’s Correlation -0.050
Sig. (2-tailed) 0.734
SCL-90
GSI Pearson’s Correlation -0.082
Sig. (2-tailed) 0.585
SOM Pearson’s Correlation -0.172
Sig. (2-tailed) 0.241
OBS Pearson’s Correlation -0.142
Sig. (2-tailed) 0.343
SENS Pearson’s Correlation -0.080
Sig. (2-tailed) 0.582
DEPR Pearson’s Correlation -0.150
Sig. (2-tailed) 0.298
ANX Pearson’s Correlation -0.148
Sig. (2-tailed) 0.307
HOST Pearson’s Correlation -0.157
Sig. (2-tailed) 0.277
PHOB Pearson’s Correlation -0.193
Sig. (2-tailed) 0.180
PARAN Pearson’s Correlation -0.056
Sig. (2-tailed) 0.704
PSYC Pearson’s Correlation -0.228
Sig. (2-tailed) 0.124
> 20) were separated by those with lower pres-
ence, thus dividing the sample in subgroups of
“dissociator” (DS+) and “no dissociator” (DS-)
patients.
The normal distribution of data was assessed
using the Shapiro-Wilk Test. Student’s t test was
performed to compare psychopathological char-
acteristics of DS+ and DS- subgroups.
The correlation between DES total score and
HAM-A, HAM-D, TCI and SCL-90 was calcu-
lated using the Pearson’s correlation test.
p < 0.05 was considered statistically significant.
Results
Overall Sample
The mean DES score in the overall sample
was 16.6. An higher score was observed in ABS
subscale (mean = 23.25) (Table I).
16 patients (32%) had DES scores > 20 and
were thus considered “dissociators”; among
these, 9 had mood disorders and 6 had anxiety
disorders. 36 patients (64%) had DES scores <
20 and were, thus, considered “no dissociators”;
among these, 19 had mood disorders and 17 had
anxiety disorders.
SCL-90 scores showed a high GSI score (1.30
± 0.73) (Table I); the subscales with the highest
mean scores were OBS (1.55 ± 1.03), DEPR (1.46
± 0.93) and ANX (1.40 ± 0.77) followed by SOM
(1.33 ± 0.81) and PARAN (1.20 ± 0.96) (Table I).
TCI showed high scores in the subscale C
(71.48 ± 13.35) and HA (65.51 ± 13.24) (Table I).
Correlation Between DES Total Score
and HAM-D, HAM-A, TCI and SCL-90
Pearson’s correlation test gave a weak, posi-
tive, linear, significant correlation (r: 0.354; p:
0.017) between the severity of depressive symp-
toms (HAM-D scores) and the presence of DS;
no significant correlations were found between
DES and HAM-A scores. A weak, positive, lin-
ear, significant correlation was also found be-
tween DES total score and the SD subscale of
TCI (r: 0.327; p: 0.022). No significant correla-
tions were found between DES total score and
SCL-90 subscales. More details are given in
Table II.
Dissociators (DS+) vs No Dissociators (DS-)
The results of SCL-90 (Table III) indicated
that DS+ patients with Anxiety Disorders pre-
sented significant differences compared with DS-
patients with anxiety disorders, showing signifi-
cant higher values in HOST (1.73 vs 0.98, p =
0.02) and PARAN (1.90 vs 1.10, p = 0.04).
Among patients with mood disorder, DS+ pa-
tients had higher scores than DS- patients in the
GSI (1.71 vs 1.17, p = 0.04) and HOST subscales
(1.69 vs 0.72 p = 0.003).
In relation to TCI scores (Table III), DS+ pa-
tients affected by a Mood Disorder presented
some significant differences in comparison with
DS-; lower values were found in RD (3.01 vs
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Table II. Correlation between DES total score and HAM-D,
HAM-A, TCI and SCL-90
*p < 0.05.
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4.26; p = 0.01), SD (3.72 vs 4.94; p = 0.03) and
C (3.09 vs 4.79; p = 0.03) subscales. Patients
with an Anxiety Disorder showed important dif-
ferences between the DS+ and DS- groups in NS
(4.12 vs 5.50 p = 0.03) and HA (6.50 vs 5.00 p =
0.01).
Discussion
DS are characterized by a disruption of and/or
discontinuity in the normal integration of con-
sciousness, memory, identity, emotion, percep-
tion, body representation, motor control, and be-
haviour; they can potentially disrupt every area
of psychological functioning3. 35% of the pa-
tients enrolled in this study had frequent DS.
This high frequency confirms the results of previ-
ous researches highlighting that unidentified DS
are often present in patients with other psychi-
atric diseases: Ball et al25 found that 69% of pa-
tients with panic disorder experienced deperson-
alization or derealization during their panic at-
tacks; similarly, finnish studies7,14 reported high
prevalence rates of dissociative symptoms in psy-
chiatric outpatients (14%) and inpatients (21%).
Significant positive correlations were found
between the presence of DS and the severity of
depressive symptoms (measured through HAM-
D). This result confirms the close association be-
tween dissociation and the severity of affective
disorders already found in previous studies. In
this regard, several reports highlighted the close
association between depressive symptoms and
dissociation13,26,27: Goff et al28 found that patients
with elevated dissociation scores had more severe
obsessive-compulsive symptoms, were more de-
pressed, and were more likely to have a personal-
ity disorder than patients with low dissociation
scores; DS in patients with bipolar disorder seem
to be correlated with early onset of the disorder
and with panic disorder co-morbidity12.
DS can considerably influence the symptom
profile and response to treatment29; higher levels
of dissociation might be a predictor of negative
treatment outcome in cognitive-behavioral thera-
py for patients with anxiety disorders and obses-
sive compulsive disorder30 and may predict poor
outcomes in inpatients participating in brief psy-
chodynamic psychotherapies31.
Higher level of dissociation may also directly
and indirectly influence the pharmacological
treatment. It is known, in fact, that dissociative
experiences reduce the response to drug therapy
and that there is a negative correlation between
DES total score and average dosages of pre-
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SCL-90 in patients with anxiety disorder SCL-90 in patients with mood disorder
DES < 20 DES > 20 p DES < 20 DES > 20 p
GSI 1.32 1.44 ns 1.17 1.71 0.04
SOM 2.40 1.86 ns 2.77 1.46 ns
OBS 1.60 1.75 ns 1.98 1.65 ns
SENS 1.33 0.82 ns 1.50 1.12 ns
DEPR 1.52 1.78 ns 1.77 1.55 ns
ANX 1.46 1.78 ns 1.15 1.58 ns
HOST 0.98 1.73 0.02 0.72 1.69 0.003
PHOB 0.93 0.60 ns 0.57 0.68 ns
PARAN 1.10 1.90 0.04 1.66 1.36 ns
PSYC 0.79 1.12 ns 0.90 0.90 ns
TCI in patients with anxiety disorder TCI in patients with mood disorder
DES < 20 DES > 20 p DES < 20 DES > 20 p
NS 5.50 4.12 0.03 4.36 4.45 ns
HA 5.00 6.50 0.01 5.97 5.36 ns
RD 3.80 5.00 ns 4.26 3.01 0.01
P 4.11 5.50 ns 4.31 4.63 ns
SD 4.83 5.50 ns 4.94 3.72 0.03
C 4.11 4.50 ns 4.79 3.09 0.03
ST 3.50 4.25 ns 3.57 4.27 ns
Table III. Dissociators vs No Dissociators.
scribed medications. Similarly, the prescription
of benzodiazepines should be discouraged in
people with dissociations, while the use of mood
stabilizers, in addition to antidepressants, seems
to be a more appropriate strategy30,32-36.
Even if DS influence the symptom profile and
the response to treatment, they are often not clin-
ically recognized because of the absence of ap-
propriate diagnostic instruments and because
clinicians are often not trained to observe disso-
ciative phenomena, usually being more focused
on more evident psychopathological issues. A
more adequate and early individuation of DS
may strongly aid physicians in achieving better
clinical outcomes.
The results of the study also indicate that some
specific characterial and temperamental aspects
may be related with DS. Personality and tem-
peramental traits like low novelty seeking and
high harm avoidance in anxious patients, and like
low reward dependence, low self-directedness
and low cooperativeness in depressed patients,
are more frequent among patients with higher
dissociative experiences. As personality typically
remains constant throughout life, these personali-
ty traits may represent predisposing factors to the
development of DS; even if it is not possible to
define a category of patients at greater risk of de-
veloping dissociative symptoms, the early identi-
fication of potentially predisposing personality
traits could be clinically helpful. In addition, the
presence of personality traits potentially predis-
posing to the development of DS contributes to
raise some doubts on the recurrent idea that DS
are exclusively caused by traumatic experi-
ences37,38.
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